Hjem › Multipelt myelom › Arizona › Scottsdale
Kliniske studier for Multipelt myelom i Scottsdale, AZ
4 studier for Multipelt myelom søker deltakere på steder i og rundt Scottsdale (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)
Rekrutterer
- Mayo Clinic in Arizona, Scottsdale
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
RekruttererFase 2/3
- Mayo Clinic Hospital Scottsdale /ID# 278349, Scottsdale
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
RekruttererFase 2
- HonorHealth, Scottsdale
A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
RekruttererFase 1
- Mayo Clinic in Arizona, Scottsdale
Multipelt myelom-studier i andre byer
- New York City, NY60 studier
- Boston, MA42 studier
- Atlanta, GA41 studier
- Houston, TX38 studier
- Durham, NC37 studier
- Nashville, TN32 studier
- Denver, CO27 studier
- Rochester, MN24 studier
- St. Louis, MO24 studier
- Columbus, OH24 studier
- Baldwin Park, CA23 studier
- Chicago, IL22 studier
Andre studier i Scottsdale
- Kreft (alle typer)18 studier
- Brystkreft18 studier
- Metastatisk kreft17 studier
- Prostatakreft17 studier
- Ikke-småcellet lungekreft15 studier
- Kolorektal kreft15 studier
- Pankreaskreft13 studier
- Melanom10 studier
- Ulcerøs kolitt8 studier
- Lungekreft8 studier
- Alzheimers sykdom7 studier
- Leverkreft (hepatocellulært karcinom)7 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.